Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 2—February 2019
Research

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12–19 Months after Illness Onset

Isabel GriffinComments to Author , Stacey W. Martin, Marc Fischer, Trudy V. Chambers, Olga Kosoy, Alyssa Falise, Olga Ponomareva, Leah D. Gillis, Carina Blackmore, and Reynald Jean
Author affiliations: Florida Department of Health in Miami–Dade County, Miami, Florida, USA (I. Griffin, A. Falise, O. Ponomareva, R. Jean); Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.W. Martin, M. Fischer, T.V. Chambers, O. Kosoy); Bureau of Public Health Laboratories, Miami (L.D. Gillis); Florida Department of Health, Tallahassee, Florida, USA (C. Blackmore)

Main Article

Figure

Zika virus IgM results for 62 participants in Miami–Dade County, Florida, USA, with PCR-confirmed Zika virus disease by follow-up specimen collection month.

Figure. Zika virus IgM results for 62 participants in Miami–Dade County, Florida, USA, with PCR-confirmed Zika virus disease by follow-up specimen collection month.

Main Article

Page created: January 16, 2019
Page updated: January 16, 2019
Page reviewed: January 16, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external